The Bear implant, from Miach Orthopaedics, does not require a second surgical wound to remove a healthy tendon from the leg, according to the company. It acts as a bridge between the two ends of a torn ACL, and the implant is absorbed into the body within eight weeks, the release said.
The Bear implant received de novo approval from the FDA in December 2020.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
